产品名称 Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) 产品规格 50µg 200µg 1mg 5mg 有效成分含量 99% 是否进口 是 用途范围 Positive Control; Immunogen; SDS-PAGE; WB. 如果需要有生物活性的蛋白,请参见活性蛋白。 包装规格 0.5kg 来源 原核表达 片段与标签 Ala2~Asp211 with N-termin...
Letter to the editor: A rare case of BCL-2-positive primary cutaneous follicle center lymphoma on the cheek with a high number of CD31 CTCs and CD31+ CTECs in the blooddoi:10.1016/j.oraloncology.2024.106949Primary cutaneous follicle-centered lymphoma...
中文名称:B-细胞淋巴瘤因子2(Bcl2)重组蛋白英文名称:Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) 保存条件:避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月纯度规格:> 97% 产品类别:重组蛋白 B-细胞淋巴瘤因子2(Bcl2)重组蛋白 物种Homo sapiens (Human,人)相同的名称,不同的物种,其它种属价格...
中文名称:B-细胞淋巴瘤因子2样蛋白(Bcl2L)重组蛋白英文名称:Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) 保存条件:避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月纯度规格:> 95% 产品类别:重组蛋白 货号::BES22544RP B-细胞淋巴瘤因子2样蛋白(Bcl2L)重组蛋白 ...
2 can be used with immunohistochemistry to identify cells containing the antigen. In healthy tissue, these antibodies will react with B-cells in the mantle zone, as well as some T-cells. However, there is a considerable increase in positive cells in follicular lymphoma, as well as many other...
中文名称:B-细胞淋巴-瘤因子2(Bcl2)重组蛋白 英文名称:Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) 保存条件:避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月 纯度规格:> 97% 产品类别:重组蛋白 B-细胞淋巴-瘤因子2(Bcl2)重组蛋白 物种Homo sapiens (Human,人) 相同的名称,不同的物种,其它...
2-10 µg/mg lysate - 产品规格 种属反应 Human 宿主/亚型 Rabbit / IgG 分类 Polyclonal 类型 Antibody 抗原 Region between residue 50 and 100 of human B-cell CLL/lymphoma 2. 查看免疫原 偶联物 Unconjugated 形式 Liquid 浓度 1 mg/mL
BCL-2 Antibody (MA5-35345) in IHC (P) Immunohistochemical analysis of BCL-2 was performed using formalin-fixed paraffin-embedded human colon (diffuse large B cell lymphoma) tissue sections. To expose the target protein, heat-induced epitope retrieval was performed on de-paraffinized sections us...
IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R-CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDYdoi:10.1002/hon.95_2629John Wiley & Sons, LtdHematological Oncology...
31. Wang XJ, Medeiros LJ, Lin P, Yin CC, Hu S, Thompson MA, Li S. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse larg...